Clinical Trials Browser

Phase 1 × Terminated × pazopanib × Clear all

NCT01407562 2022-09-28

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Phase 1 Terminated

BreastOther solid neoplasm

Unspecified Adult Solid Tumor - Protocol Specific

NCT01548144 2021-09-13

Pazopanib or Pemetrexed and Crizotinib in Advanced Cancer

Phase 1 Terminated

Advanced Cancers

NCT02795819 2019-10-24

Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer

Phase 1 Terminated

6 enrolled 12 charts

GenitourinarySarcoma

Carcinoma, Renal Cell, Neoplasm Metastasis, Sarcoma

NCT01642017 2018-08-06

VOTRAGE

Phase 1 Terminated

Neoplasm Metastasis

NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Phase 1 Terminated

31 enrolled 12 charts

BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

NCT01542047 2015-06-18

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

Phase 1 Terminated

Neoplasm Metastasis

NCT00450879 2015-03-25

Pazopanib in Treating Patients With Newly Diagnosed or Locally and/or Regionally Recurrent Breast Cancer That Can Be Removed By Surgery

Phase 1 Terminated

Breast Neoplasms, Breast Neoplasms, Male

NCT01060514 2013-10-30

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Phase 1 Terminated

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms